Full Name
Alan Prem Kumar
Variants
Kumar, A.P.
Kumar, A.
Prem Kumar, A.
Kumar, Alan Prem Rem
 
 
 
Email
apkumar@nus.edu.sg
 
Other emails
 

Publications

Refined By:
Department:  DEAN'S OFFICE (MEDICINE)
Date Issued:  [2020 TO 2024]
Date Issued:  2022

Results 1-14 of 14 (Search time: 0.02 seconds).

Issue DateTitleAuthor(s)
11-Jul-20222,3,5,6-Tetramethylpyrazine Targets Epithelial-Mesenchymal Transition by Abrogating Manganese Superoxide Dismutase Expression and TGF beta-Driven Signaling Cascades in Colon Cancer CellsJung, Young Yun; Mohan, Chakrabhavi Dhananjaya; Eng, Huiyan; Narula, Acharan S; Namjoshi, Ojas A; Blough, Bruce E; Rangappa, Kanchugarakoppal S; Sethi, Gautam ; Kumar, Alan Prem ; Ahn, Kwang Seok
26-May-2022Correction: The long and short non-coding RNAs modulating EZH2 signaling in cancer (vol 15, 18, 2022)Mirzaei, Sepideh; Gholami, Mohammad Hossein; Hushmandi, Kiavash; Hashemi, Farid; Zabolian, Amirhossein; Canadas, Israel; Zarrabi, Ali; Nabavi, Noushin; Aref, Amir Reza; Crea, Francesco; Wang, Yuzhuo; Ashrafizadeh, Milad; Kumar, Alan Prem 
31-Sep-2022Demystifying the Functional Role of Nuclear Receptors in Esophageal CancerJayaprakash, Sujitha; Hegde, Mangala; Girisa, Sosmitha; Alqahtani, Mohammed S; Abbas, Mohamed; Lee, E Hui Clarissa ; Yap, Kenneth Chun-Hong ; Sethi, Gautam ; Kumar, Alan Prem ; Kunnumakkara, Ajaikumar B
41-Jul-2022Differences between multimodal brain-age and chronological-age are linked to telomere shorteningYu, Junhong ; Kanchi, Madhu Mathi ; Rawtaer, Iris ; Feng, Lei ; Kumar, Alan Prem ; Kua, Ee-Heok ; Mahendran, Rathii 
53-Apr-2022Doxorubicin-loaded graphene oxide nanocomposites in cancer medicine: Stimuli-responsive carriers, co-delivery and suppressing resistanceM Ashrafizadeh; Hamidreza Saebfar; Mohammad Hossein Gholami; Kiavash Hushmandi; Amirhossein Zabolian; Pooria Bikarannejad; Mehrdad Hashemi; Salman Daneshi; Sepideh Mirzaei; Esmaeel Sharifi; Alan Kumar ; Haroon Khan; Hamid Heydari Sheikh Hossein; Massoud Vosough; Navid Rabiee; Vijay Kumar Thakur; Pooyan Makvandi; Yogendra Mishra; Franklin Tay; Yuzhuo Wang; Ali Zarrabi; Gorka Orive; Ebrahim Mostafavi
628-Jun-2022Emerging role of exosomes in cancer progression and tumor microenvironment remodelingPaskeh, Mahshid Deldar Abad; Entezari, Maliheh; Mirzaei, Sepideh; Zabolian, Amirhossein; Saleki, Hossein; Naghdi, Mohamad Javad; Sabet, Sina; Khoshbakht, Mohammad Amin; Hashemi, Mehrdad; Hushmandi, Kiavash; Sethi, Gautam ; Zarrabi, Ali; Kumar, Alan Prem ; Tan, Shing Cheng; Papadakis, Marios; Alexiou, Athanasios; Islam, Md Asiful; Mostafavi, Ebrahim; Ashrafizadeh, Milad
71-Jan-2022Exosomes as Promising Nanostructures in Diabetes Mellitus: From Insulin Sensitivity to Ameliorating Diabetic ComplicationsAshrafizadeh, M; Kumar, AP ; Aref, AR; Zarrabi, A; Mostafavi, E
81-Mar-2022Ionic Liquid-Assisted Fabrication of Bioactive Heterogeneous Magnetic Nanocatalyst with Antioxidant and Antibacterial Activities for the Synthesis of Polyhydroquinoline DerivativesMirani Nezhad, Shefa; Nazarzadeh Zare, Ehsan; Davarpanah, Azimeh; Pourmousavi, Seied Ali; Ashrafizadeh, Milad; Kumar, Alan Prem 
91-Dec-2022Molecular Landscape of LncRNAs in Prostate Cancer: A focus on pathways and therapeutic targets for interventionMirzaei, S; Paskeh, MDA; Okina, E ; Gholami, MH; Hushmandi, K; Hashemi, M; Kalu, A; Zarrabi, A; Nabavi, N; Rabiee, N; Sharifi, E; Karimi-Maleh, H; Ashrafizadeh, M; Kumar, AP ; Wang, Y
1017-Jun-2022(Nano)platforms in bladder cancer therapy: Challenges and opportunitiesAshrafizadeh, Milad; Zarrabi, Ali; Karimi-Maleh, Hassan; Taheriazam, Afshin; Mirzaei, Sepideh; Hashemi, Mehrdad; Hushmandi, Kiavash; Makvandi, Pooyan; Nazarzadeh Zare, Ehsan; Sharifi, Esmaeel; Goel, Arul; Wang, Lingzhi ; Ren, Jun; Nuri Ertas, Yavuz; Kumar, Alan Prem ; Wang, Yuzhuo; Rabiee, Navid; Sethi, Gautam ; Ma, Zhaowu
1124-Mar-2022PI3K/AKT Signaling Tips the Balance of Cytoskeletal Forces for Cancer ProgressionDeng, Shuo ; Leong, Hin Chong ; Datta, Arpita ; Gopal, Vennila; Kumar, Alan Prem ; Yap, Celestial T 
121-Dec-2022Targeting autophagy in prostate cancer: preclinical and clinical evidence for therapeutic responseAshrafizadeh, M; Paskeh, MDA; Mirzaei, S; Gholami, MH; Zarrabi, A; Hashemi, F; Hushmandi, K; Hashemi, M; Nabavi, N; Crea, F; Ren, J; Klionsky, DJ; Kumar, AP ; Wang, Y
131-May-2022Targeting Nuclear Receptors in Lung Cancer-Novel Therapeutic ProspectsGangwar, Shailendra Kumar; Kumar, Aviral; Yap, Kenneth Chun-Hong ; Jose, Sandra; Parama, Dey; Sethi, Gautam ; Kumar, Alan Prem ; Kunnumakkara, Ajaikumar B
142-Mar-2022The long and short non-coding RNAs modulating EZH2 signaling in cancerMirzaei, Sepideh; Gholami, Mohammad Hossein; Hushmandi, Kiavash; Hshemi, Farid; Zabolian, Amirhossein; Canadas, Israel; Zarrabi, Ali; Nabavi, Noushin; Aref, Amir Reza; Crea, Francesco; Wang, Yuzhuo; Ashrafizadeh, Milad; Kumar, Alan Prem